Table 1

Observation and follow-up schedule

Timing of evaluationBefore ERCP2 hours after ERCPA day after ERCP30 days after ERCP
Day−28∼00130
Consent
Patients background
Imaging (US, CT, MRI, EUS)
Pathology, biopsy←Δ→*
Symptoms
Vital signs
Laboratory data
Adverse event←○→†
  • *not mandatory.

  • †evaluate depending on the ASGE criteria.

  • ASGE, American Society for Gastrointestinal Endoscopy; ERCP, endoscopic retrograde cholangiopancreatography; EUS, endoscopic ultrasound; US, ultrasound.